Tiziana实现"肺部靶向递送"抗IL-6R单抗,以高效治疗新冠病毒COVID-19感染患者

2020-04-09 MedSci原创 MedSci原创

Tiziana的这项技术可以使用手持吸入器或雾化器将抗IL-6受体(anti-IL-6R)单克隆抗体(mAb)TZLS-501直接递送到肺中。

Tiziana的这项技术可以使用手持吸入器或雾化器将抗IL-6受体(anti-IL-6R)单克隆抗体(mAb)TZLS-501直接递送到肺中。

该公司董事长Gabriele Cerrone说:"使用便携式手持吸入器或雾化器将抗IL-6R mAb直接递送至肺部,对于感染了新型冠状病毒COVID-19的儿童和成人是一种快速、直接的治疗方法。"

"重要的是,用我们的全人源抗IL-6R mAb单抗有可能用于COVID-19感染患者的长期治疗,以阻止患者病情发展并降低死亡率。"

感染COVID-19的患者可能会产生不受控制的免疫反应(称为细胞因子风暴),从而导致促炎细胞因子和其他炎症蛋白的大量产生,如IL-6、肿瘤坏死因子-α(TNF-a)和粒细胞-巨噬细胞集落刺激因子(GM-CSF),引起肺组织的严重损伤,导致患者呼吸衰竭和死亡。

在这些细胞因子中,IL-6似乎是冠状病毒介导呼吸衰竭的主要元凶。国内医生进行的早期临床研究表明,抗IL6R mAb可能在临床实践中用于治疗COVID-19。

Tiziana认为TZLS-501(抗IL6R单抗)与这种新引入的吸入技术相结合可以迅速抑制肺部炎症。

原始出处:

http://www.pharmatimes.com/news/tiziana_develops_delivery_tech_for_covid-19_treatment_1338011

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1633572, encodeId=e07216335e257, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Wed Oct 14 15:47:11 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1851028, encodeId=f4561851028cc, content=<a href='/topic/show?id=0406580667c' target=_blank style='color:#2F92EE;'>#新冠病毒COVID-19#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58066, encryptionId=0406580667c, topicName=新冠病毒COVID-19)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f00658, createdName=yyanpro@21cn.c, createdTime=Thu Jan 28 00:47:11 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273789, encodeId=6d8b12e37893d, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349852, encodeId=fd0013498528b, content=<a href='/topic/show?id=6c5796e898' target=_blank style='color:#2F92EE;'>#IL-6R#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9678, encryptionId=6c5796e898, topicName=IL-6R)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616292, encodeId=ddc7161629242, content=<a href='/topic/show?id=6ec35510564' target=_blank style='color:#2F92EE;'>#抗IL-6R单抗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55105, encryptionId=6ec35510564, topicName=抗IL-6R单抗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2ac19732989, createdName=紫砂壶, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027733, encodeId=d034102e7333e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Apr 10 00:47:11 CST 2020, time=2020-04-10, status=1, ipAttribution=)]
    2020-10-14 AspirantSuo
  2. [GetPortalCommentsPageByObjectIdResponse(id=1633572, encodeId=e07216335e257, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Wed Oct 14 15:47:11 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1851028, encodeId=f4561851028cc, content=<a href='/topic/show?id=0406580667c' target=_blank style='color:#2F92EE;'>#新冠病毒COVID-19#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58066, encryptionId=0406580667c, topicName=新冠病毒COVID-19)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f00658, createdName=yyanpro@21cn.c, createdTime=Thu Jan 28 00:47:11 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273789, encodeId=6d8b12e37893d, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349852, encodeId=fd0013498528b, content=<a href='/topic/show?id=6c5796e898' target=_blank style='color:#2F92EE;'>#IL-6R#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9678, encryptionId=6c5796e898, topicName=IL-6R)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616292, encodeId=ddc7161629242, content=<a href='/topic/show?id=6ec35510564' target=_blank style='color:#2F92EE;'>#抗IL-6R单抗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55105, encryptionId=6ec35510564, topicName=抗IL-6R单抗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2ac19732989, createdName=紫砂壶, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027733, encodeId=d034102e7333e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Apr 10 00:47:11 CST 2020, time=2020-04-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1633572, encodeId=e07216335e257, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Wed Oct 14 15:47:11 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1851028, encodeId=f4561851028cc, content=<a href='/topic/show?id=0406580667c' target=_blank style='color:#2F92EE;'>#新冠病毒COVID-19#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58066, encryptionId=0406580667c, topicName=新冠病毒COVID-19)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f00658, createdName=yyanpro@21cn.c, createdTime=Thu Jan 28 00:47:11 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273789, encodeId=6d8b12e37893d, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349852, encodeId=fd0013498528b, content=<a href='/topic/show?id=6c5796e898' target=_blank style='color:#2F92EE;'>#IL-6R#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9678, encryptionId=6c5796e898, topicName=IL-6R)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616292, encodeId=ddc7161629242, content=<a href='/topic/show?id=6ec35510564' target=_blank style='color:#2F92EE;'>#抗IL-6R单抗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55105, encryptionId=6ec35510564, topicName=抗IL-6R单抗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2ac19732989, createdName=紫砂壶, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027733, encodeId=d034102e7333e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Apr 10 00:47:11 CST 2020, time=2020-04-10, status=1, ipAttribution=)]
    2020-04-11 kzlchina
  4. [GetPortalCommentsPageByObjectIdResponse(id=1633572, encodeId=e07216335e257, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Wed Oct 14 15:47:11 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1851028, encodeId=f4561851028cc, content=<a href='/topic/show?id=0406580667c' target=_blank style='color:#2F92EE;'>#新冠病毒COVID-19#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58066, encryptionId=0406580667c, topicName=新冠病毒COVID-19)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f00658, createdName=yyanpro@21cn.c, createdTime=Thu Jan 28 00:47:11 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273789, encodeId=6d8b12e37893d, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349852, encodeId=fd0013498528b, content=<a href='/topic/show?id=6c5796e898' target=_blank style='color:#2F92EE;'>#IL-6R#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9678, encryptionId=6c5796e898, topicName=IL-6R)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616292, encodeId=ddc7161629242, content=<a href='/topic/show?id=6ec35510564' target=_blank style='color:#2F92EE;'>#抗IL-6R单抗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55105, encryptionId=6ec35510564, topicName=抗IL-6R单抗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2ac19732989, createdName=紫砂壶, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027733, encodeId=d034102e7333e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Apr 10 00:47:11 CST 2020, time=2020-04-10, status=1, ipAttribution=)]
    2020-04-11 jklm09
  5. [GetPortalCommentsPageByObjectIdResponse(id=1633572, encodeId=e07216335e257, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Wed Oct 14 15:47:11 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1851028, encodeId=f4561851028cc, content=<a href='/topic/show?id=0406580667c' target=_blank style='color:#2F92EE;'>#新冠病毒COVID-19#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58066, encryptionId=0406580667c, topicName=新冠病毒COVID-19)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f00658, createdName=yyanpro@21cn.c, createdTime=Thu Jan 28 00:47:11 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273789, encodeId=6d8b12e37893d, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349852, encodeId=fd0013498528b, content=<a href='/topic/show?id=6c5796e898' target=_blank style='color:#2F92EE;'>#IL-6R#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9678, encryptionId=6c5796e898, topicName=IL-6R)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616292, encodeId=ddc7161629242, content=<a href='/topic/show?id=6ec35510564' target=_blank style='color:#2F92EE;'>#抗IL-6R单抗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55105, encryptionId=6ec35510564, topicName=抗IL-6R单抗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2ac19732989, createdName=紫砂壶, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027733, encodeId=d034102e7333e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Apr 10 00:47:11 CST 2020, time=2020-04-10, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1633572, encodeId=e07216335e257, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Wed Oct 14 15:47:11 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1851028, encodeId=f4561851028cc, content=<a href='/topic/show?id=0406580667c' target=_blank style='color:#2F92EE;'>#新冠病毒COVID-19#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58066, encryptionId=0406580667c, topicName=新冠病毒COVID-19)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f00658, createdName=yyanpro@21cn.c, createdTime=Thu Jan 28 00:47:11 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273789, encodeId=6d8b12e37893d, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349852, encodeId=fd0013498528b, content=<a href='/topic/show?id=6c5796e898' target=_blank style='color:#2F92EE;'>#IL-6R#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9678, encryptionId=6c5796e898, topicName=IL-6R)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616292, encodeId=ddc7161629242, content=<a href='/topic/show?id=6ec35510564' target=_blank style='color:#2F92EE;'>#抗IL-6R单抗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55105, encryptionId=6ec35510564, topicName=抗IL-6R单抗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2ac19732989, createdName=紫砂壶, createdTime=Sat Apr 11 12:47:11 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027733, encodeId=d034102e7333e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Apr 10 00:47:11 CST 2020, time=2020-04-10, status=1, ipAttribution=)]
    2020-04-10 公卫新人

    新冠肺炎,疫情何时才能消失

    0